⚠️ This provider averages 921 services per working day — physically unusual for an individual practitioner
Based on 2.3M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $27.8M in total Medicare payments ranks in the 99th percentile of Pathology providers nationally.
Averaging 921 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 2155% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 269% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $168.56 | $39.91 | 4.22x | $128.65 | $183.5K | 4.6K | 16 |
| 2015 | $171.03 | $46.62 | 3.67x | $124.41 | $245.2K | 5.3K | 24 |
| 2016 | $27.90 | $6.29 | 4.44x | $21.61 | $712.7K | 113.2K | 39 |
| 2017 | $28.37 | $6.31 | 4.50x | $22.06 | $1.2M | 190.0K | 44 |
| 2018 | $26.93 | $5.54 | 4.86x | $21.39 | $1.3M | 233.4K | 40 |
| 2019 | $28.27 | $5.96 | 4.74x | $22.31 | $1.8M | 297.9K | 56 |
| 2020 | $66.62 | $19.28 | 3.46x | $47.34 | $6.5M | 339.3K | 64 |
| 2021 | $64.38 | $16.36 | 3.94x | $48.02 | $6.9M | 419.5K | 64 |
| 2022 | $52.39 | $12.96 | 4.04x | $39.43 | $4.9M | 374.5K | 61 |
| 2023 | $35.69 | $12.78 | 2.79x | $22.91 | $4.1M | 323.9K | 64 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 107.1K | $9.0M | $84.24 | 3.56x |
| 36415 | Insertion of needle into vein for collection of blood sample | 1.9M | $6.9M | $3.74 | 4.81x |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 74.6K | $2.0M | $26.40 | 3.56x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 64.7K | $1.6M | $24.91 | 3.01x |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 39.6K | $1.4M | $34.81 | 5.03x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 16.9K | $589.6K | $34.88 | 2.83x |
| 87493 | Detection test by nucleic acid for clostridium difficile, amplified probe technique | 12.1K | $480.9K | $39.84 | 3.78x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 11.5K | $403.1K | $35.16 | 2.81x |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | 11.1K | $387.7K | $34.93 | 3.15x |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 9.2K | $322.7K | $35.05 | 3.41x |
| 87522 | Detection test by nucleic acid for hepatitis c virus, quantification | 5.7K | $272.6K | $47.50 | 3.78x |
| 87902 | Analysis test by nucleic acid for hepatitis c virus | 1.0K | $267.1K | $265.21 | 2.84x |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 7.2K | $252.2K | $34.88 | 2.83x |
| 88374 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 2.1K | $230.8K | $111.56 | 2.42x |
| 87536 | Detection test by nucleic acid for hiv-1 virus, quantification | 2.2K | $208.5K | $93.34 | 3.82x |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 1.5K | $205.3K | $140.30 | 3.05x |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 5.7K | $199.1K | $35.06 | 2.82x |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 5.6K | $195.6K | $35.01 | 3.14x |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 5.4K | $189.2K | $35.09 | 2.81x |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | 4.0K | $159.5K | $40.07 | 2.05x |
This provider submits charges 3.8 times higher than what Medicare actually pays.
A markup ratio of 3.8x means for every $100 Medicare pays, this provider initially charges $380. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Pathology providers in TN for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Richard Kinsey, MD | Memphis, TN | $40.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data